![Eric S. Furfine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric S. Furfine
Directeur Technique/Scientifique/R&D chez
Mosaic Biosciences, Inc.
Profil
Eric S.
Furfine currently works at Ingenia Therapeutics Inc., as Director and Mosaic Biosciences, Inc., as Chief Scientific Officer from 2025.
Dr. Furfine also formerly worked at GlaxoSmithKline LLC, as Director-Biochemical Analytical Pharmacology, Regeneron Pharmaceuticals, Inc., as Vice President-PreClinical Development, ImmuneXcite, Inc., as Chief Executive & Scientific Officer in 2016, Adnexus, as SVP-Research & Preclinical Development, and Sesen Bio, Inc., as Chief Scientific Officer from 2014 to 2016.
Dr. Furfine received his undergraduate degree from Washington University in St. Louis and doctorate degree from Brandeis University.
Postes actifs de Eric S. Furfine
| Sociétés | Poste | Début |
|---|---|---|
Ingenia Therapeutics Inc.
 Ingenia Therapeutics Inc. Medical/Nursing ServicesHealth Services Provides health care services | Directeur/Membre du Conseil | - |
Mosaic Biosciences, Inc.
 Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial research and development services | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Eric S. Furfine
| Sociétés | Poste | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 05/02/2016 |
ImmuneXcite, Inc.
 ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which develops monoclonal antibodies for cancer | Directeur Général | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Directeur Technique/Scientifique/R&D | - |
Formation de Eric S. Furfine
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mosaic Biosciences, Inc.
Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial research and development services | Commercial Services |
ImmuneXcite, Inc.
ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which develops monoclonal antibodies for cancer | Health Technology |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Ingenia Therapeutics Inc.
Ingenia Therapeutics Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
